Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,225 | -3,852 | -811 | -936 | 1,320 |
| Depreciation Amortization | 861 | 561 | 259 | 1,018 | 666 |
| Accounts receivable | -2,179 | -1,462 | -829 | -1,559 | -1,643 |
| Accounts payable and accrued liabilities | 836 | 284 | 414 | 53 | -52 |
| Other Working Capital | 1,662 | 376 | -2,760 | 3,514 | 2,005 |
| Other Operating Activity | 3,779 | 2,875 | 1,254 | 4,725 | 4,132 |
| Operating Cash Flow | $1,734 | $-1,218 | $-2,473 | $6,815 | $6,428 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -14 | -14 | N/A | N/A |
| Purchase Sale Intangibles | -1,868 | -1,868 | -1,868 | -775 | N/A |
| Other Investing Activity | -1,868 | -1,868 | -1,868 | -775 | 0 |
| Investing Cash Flow | $-1,882 | $-1,882 | $-1,882 | $-775 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,155 | -770 | -385 | -1,155 | -770 |
| Common Stock Issued | 176 | 176 | 7 | 378 | 288 |
| Other Financing Activity | 0 | 0 | 0 | -180 | -181 |
| Financing Cash Flow | $-979 | $-594 | $-378 | $-957 | $-663 |
| Beginning Cash Position | 21,388 | 21,388 | 21,388 | 16,305 | 16,305 |
| End Cash Position | 20,261 | 17,694 | 16,655 | 21,388 | 22,070 |
| Net Cash Flow | $-1,127 | $-3,694 | $-4,733 | $5,083 | $5,765 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,734 | -1,218 | -2,473 | 6,815 | 6,428 |
| Capital Expenditure | -14 | -14 | -14 | N/A | N/A |
| Free Cash Flow | 1,720 | -1,232 | -2,487 | 6,815 | 6,428 |